First Tracks Biotherapeutics, Inc. (TRAX) Institutional Ownership & Insider Trading
149 institutions reported holding First Tracks Biotherapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · read by EquiReason
TRAXFirst Tracks Biotherapeutics, Inc.Follow TRAX — free
—
Price chart with a free account
- Market cap
- 1.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters149 institutions held 92.0% of the shares. Across filers that reported both quarters, shares held changed —.
Largest moves, shares (millions)
First Tracks Biotherapeutics, Inc. — questions
- Who owns First Tracks Biotherapeutics, Inc. stock?
- 149 institutions reported First Tracks Biotherapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: EcoR1 Capital, LLC (8.9%), TCG Crossover Management, LLC (8.1%), FMR LLC (5.8%).
- Are First Tracks Biotherapeutics, Inc. insiders buying or selling?
- 2 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from First Tracks Biotherapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.